🇺🇸

US SEC Filing Intelligence

· daily

Federal Professional Services Contracts — April 15, 2026

Two DOE professional services contracts totaling $293,785,850 in obligations highlight sustained civilian agency spending on security studies and IT support, with 0/2 defense-related awards. UNWIN CO's $213.8M small business set-aside contract (materiality 8/10) leads as the highest-conviction bullish signal, featuring $178.6M already outlayed and revenue visibility through April 2026. Bluewater Federal Solutions, Inc. (Tetra Tech, Inc. subsidiary) adds $80M obligated (potential $96.9M ceiling) in IT services, with $62.8M outlayed through September 2026. Dominant theme is DOE Headquarters Procurement Services prioritizing long-duration time-and-materials awards to small businesses. Key watch item: outlay progress on remaining balances amid 2026 contract end dates.

2 total filings
· daily

Federal IT & Cybersecurity Contracts — April 15, 2026

These three civilian federal IT and cybersecurity contracts total $482,277,261 in obligations, with 0/3 defense-related, highlighting momentum in civilian agency spending on IT services via full and open competition. Dominant themes include historical DHS backlog for General Dynamics Information Technology, Inc. and long-term growth commitments to small businesses SOFTRAMS LLC at HHS/CMS ($88M obligated, $57M outlayed) and CLOUDSHAPE LLC at USAID ($64M obligated, $33M outlayed). Highest-conviction signals are bullish on SOFTRAMS LLC and CLOUDSHAPE LLC due to significant outlays and multi-year horizons extending to 2029 and 2032. A key risk is zero outlays on the largest contract to General Dynamics Information Technology, Inc. ($330M DHS obligation, performance ended 2015), signaling dormant backlog.

3 total filings
· daily

All HHS Contracts — April 15, 2026

HHS awarded a single $88,157,680 obligation delivery order to SOFTRAMS LLC under full and open competition, representing 100% civilian contracts with zero defense exposure during the April 15, 2026 period. The contract supports CMS's Quality Payment Program via custom computer programming services (NAICS 541511), with $56,978,236 already outlayed and potential expansion to $195,527,844 including options. This signals a major revenue commitment for the small HUBZone, minority-owned firm, providing ~$15-17M in estimated annual revenue over ~5.75 years. Highest-conviction bullish signal is immediate revenue recognition from high outlays on this firm fixed price award. Key watch item: option exercises toward the $195M ceiling and outlay progression versus total obligation. High pricing risk exists due to the firm fixed price structure.

1 total filings
· daily

All DOE Contracts — April 15, 2026

DOE awarded $293,785,850 in total obligations across two long-term civilian contracts during the April 15, 2026 period, with 0/2 defense-related and both signaling bullish revenue visibility through 2026. Dominant themes center on DOE Headquarters Procurement Services funding security studies/analysis (UNWIN CO at $213.8M) and IT/engineering support (Bluewater Federal Solutions at $80M), both time-and-materials structures with substantial outlays ($178.6M and $62.8M respectively). Highest-conviction signal is UNWIN CO's small business set-aside securing dedicated ~$35M annual revenue through April 2026 amid strong execution. A key risk is medium pricing risk on time-and-materials terms, with investors watching remaining outlay progress and option exercises toward full ceilings.

2 total filings
· daily

Mega Contracts Monitor ($100M+) — April 15, 2026

These four civilian mega contracts totaling $2,981,670,287 across Department of State, DHS, DOE, and Treasury highlight sustained funding in security consulting, IT services, and specialized manufacturing, with zero defense exposure. XATOR LLC's $2.31B Department of State award leads as the highest-conviction bullish signal due to its top materiality score of 8/10. UNWIN CO's $213.8M DOE small business set-aside through 2026-04-13 adds revenue visibility with $178.6M already outlayed. Key risk is General Dynamics Information Technology's $330M DHS contract showing $0 outlayed since its 2015 end date, signaling dormant historical backlog.

4 total filings
· daily

High-Value Federal Grants ($5M+) — April 15, 2026

This digest covers $3,349,025,927 in high-value federal grants ($5M+) awarded or active during April 15, 2026, with 0/9 defense-related and all civilian agency obligations. Dominant themes include long-duration IT and technical support contracts to DOE ($293.8M across UNWIN CO and Bluewater Federal Solutions), HHS ($88.2M to SOFTRAMS LLC), and DHS ($330M to General Dynamics IT), signaling steady civilian spending in IT services and security analysis. Highest-conviction bullish signal is XATOR LLC's $2.31B Department of State contract (materiality 8/10), providing massive revenue potential despite limited details. Key risk is execution uncertainty from low or zero outlays on historical contracts like General Dynamics IT's $330M DHS award ($0 outlayed post-2015). Investors should monitor option exercises and outlay progress for revenue realization in public parents like General Dynamics (GD) and Tetra Tech (TTEK).

9 total filings
· daily

DOE Energy Grants — April 15, 2026

Two DOE contracts totaling $293,785,850 in obligations highlight sustained civilian agency spending on long-duration technical support services, with 0/2 defense-related and both running through mid-to-late 2026. UNWIN CO's $213,772,540 small business set-aside for security studies/analysis (materiality 8/10) represents the highest-conviction bullish signal, providing ~$35M annual revenue visibility amid $178.6M already outlayed. Bluewater Federal Solutions, Inc. (Tetra Tech, Inc. subsidiary) adds $80,013,310 for IT support with $62.8M outlayed and potential to $96.9M ceiling. Dominant theme is DOE Headquarters Procurement Services prioritizing time-and-materials vehicles for enterprise support. Key watch item: outlay progress on remaining balances ($35M for UNWIN, ~$17M+ for Bluewater) ahead of 2026 performance end dates.

2 total filings
· daily

General Federal Contracts — April 15, 2026

This digest covers 9 civilian federal contracts totaling $3,349,025,927 in obligations from April 15-15, 2026, with 0/9 defense-related awards spanning agencies including State, DHS, DOE, Treasury, HHS, NASA, USAID, and PBGC. Dominant theme is long-duration civilian IT, engineering, and support services, led by Department of State's $2.31B award to XATOR LLC as the highest-conviction bullish signal for revenue visibility. Other notable awards include DOE's $213.8M to UNWIN CO and $80M to Bluewater Federal Solutions (Tetra Tech subsidiary). Key risk is uneven outlay progress, with General Dynamics IT at $0 outlayed on its $330M DHS contract despite historical obligation.

9 total filings
· daily

All NASA Contracts — April 15, 2026

NASA obligated $71,027,408 across one civilian contract to PCI Productions LLC for agencywide communication services, representing 0% defense exposure in this stream. The dominant theme is NASA Kennedy Space Center's reliance on 8(a) set-aside awards to small disadvantaged businesses like PCI, a Huntsville, AL-based firm with a $202,609,441 ceiling including options. Already $58,312,636 outlayed on this firm-fixed price contract since June 2023, signaling steady execution but neutral investment implications due to PCI's private small business status and non-technical public relations focus (NAICS 541820). Highest-conviction signal is neutral niche growth potential toward the $202M ceiling. Key watch item: option exercise progress and performance milestones through May 2027 (potential 2028 extension), amid high pricing risk.

1 total filings
· daily

S&P 500 Technology Sector SEC Filings — April 15, 2026

Across 12 filings in the USA S&P 500 Technology stream, themes emerge of mixed operational progress amid persistent cash constraints and strategic expansions in AI infrastructure, with revenue growth in niche areas like uranium (+131% YoY) and AI data centers contrasting zero-revenue tech firms like Madison Technologies. Period-over-period trends show loss narrowing in 3/12 companies (Western Uranium -29% net loss YoY, Mosaic ImmunoEngineering -25% YoY) but expanding losses and liabilities elsewhere (Madison +6.4% loss, +14% liabilities), alongside neutral 13F disclosures revealing heavy tech ETF and stock exposure (NVIDIA, Apple in top holdings). Forward-looking catalysts include BlockchAIn Digital Infrastructure's +305 MW AI capacity pipeline by 2026-2027 and AParadise Acquisition's SPAC merger closing early May 2026 with Enhanced Games launch May 24. M&A activity (Esquire S-4 merger proxy) and board enhancements (Ribbon Communications) signal consolidation, while CEO returns (Saga) and institutional holdings (Cisco's CoreWeave stake) bolster conviction. Portfolio-level patterns indicate AI-themed bets amid cash burn risks, with 4/12 filings positive on growth pipelines but 5/12 flagging liquidity woes, implying selective opportunities in infra over pure software plays.

7 high priority 5 medium 12 total filings
· daily

Nasdaq 100 Stocks SEC Filings — April 15, 2026

Across 14 SEC filings from NASDAQ-100 related entities and peers, key themes include stark contrasts in financial health: robust revenue growth in niche players like Western Uranium (+131.5% YoY) and OneMeta (massive surge from $31k to $1.5M) offset by persistent zero revenues and widening losses in development-stage firms (MDEX, LAAI, Mosaic). Capital allocation shines with Costco's 13% dividend hike signaling confidence, while operating losses narrowed in mining (Western) and immunoengineering (Mosaic) amid cost cuts. Institutional 13F filings (Wealth Intelligence, Cisco, Murphy Middleton) reveal concentrated ETF/large-cap bets with neutral sentiment, no major shifts. Positive management updates (Saga CEO return, Ribbon board addition, IPM post-acquisition growth) contrast going concern warnings and cash burn. Portfolio-level trends show 4/7 10-Ks with revenue growth or stability but universal net losses, liabilities rising in 4 cases (avg +30% YoY), highlighting high-risk turnaround potential in small caps vs. stability in retail/broadcasting. Upcoming catalysts cluster in May 2026 (mergers, AGMs, dividends, events) offer timed alpha amid mixed sentiment (7 mixed/negative).

9 high priority 5 medium 14 total filings
· daily

S&P 500 Financials Sector SEC Filings — April 15, 2026

Across 50 filings in the USA S&P 500 Financials stream (broadly including banks, insurers, asset managers, REITs, and advisors), sentiment is predominantly neutral-to-mixed, with 13F filings from 14 asset managers/advisors revealing heavy ETF allocations (e.g., S&P 500, QQQ, broad market) signaling defensive positioning amid market highs. Financial performers like M&T Bank showed resilient YoY EPS growth (+24% to $4.13) and NIM expansion to 3.71% despite QoQ softness and CRE loan declines (-11% YoY), while Chunghwa Telecom (adjacent financial services exposure) guided capex up to NT$31.9B for 2026 (+15% YoY). Capital allocation trends favor buybacks (M&T $1.25B, News Corp $1B program) and dividends (Chunghwa NT$5.20/share), but smaller names face dilution risks from offerings (TeraWulf $900M, Soluna SEPA) and Nasdaq compliance issues. M&A activity (Mission/Calavo merger taxes capped at $5M, Galera/Obsidian all-stock deal) and leadership shifts (World Acceptance interim CEO) highlight restructuring, with portfolio-level margin pressures in 4/6 reporting firms (avg efficiency ratio up 300bps). Key implication: Banks stable but watch CRE/nonaccruals; advisors bullish on mega-caps/ETFs; alpha in merger catalysts and cost-cutters like Snap ($500M savings runway).

20 high priority 30 medium 50 total filings
· daily

S&P 500 Consumer Staples Sector SEC Filings — April 15, 2026

Across 50 SEC filings from the S&P 500 Consumer Staples stream (broadened to related sectors), sentiment is predominantly neutral/mixed with pockets of positive capital returns and negative operational pressures; key period-over-period trends show modest revenue growth averaging 3-5% YoY in reporting firms like Selectis Health (+5%), Chunghwa Telecom (+2.7%), and Cosmofarm (+15% wholesale), but sharp declines in others like Sotherly Hotels (-3% revenue, -38.5% NOI) and heavy losses in biotechs/REITs. Dividend hikes signal shareholder focus in staples (Costco +13% to $1.47/share, Chunghwa NT$5.20/share), contrasting with rising debt and liquidity strains (Strawberry Fields $752M debt, Selectis senior notes +55% to $1.59M). Executive appointments (Regis, Prelude Therapeutics) and JV deals (Limoneira composting) highlight strategic pivots, while prelim guidance holds firm despite Q1 softness (QuidelOrtho $615-620M revenue). Portfolio-level patterns reveal margin compression in hospitality/healthcare (avg -200bps+ in Sotherly/Selectis) vs. EPS gains in industrials (PPG +6%, nVent +35%), with capex upticks (Chunghwa +15% to NT$31.9B 2026) pointing to infrastructure bets. Market implications favor defensive staples amid volatility, with catalysts like May earnings/AGMs driving near-term moves.

27 high priority 23 medium 50 total filings
· daily

S&P 500 Industrials Sector SEC Filings — April 15, 2026

Across 50 filings in the USA S&P 500 Industrials intelligence stream (broadly encompassing aerospace, defense, machinery, transportation, construction, and adjacent sectors like energy/utilities), dominant themes include robust M&A/SPAC activity (e.g., BOXABL $3.5B merger, Pantages amendment, Aspire $30M LOI), debt refinancings/extensions (Basin Electric $700M exchange, US Physical Therapy credit amend), and mixed bank earnings spillovers impacting industrial financing (BofA +17% YoY NI, M&T +14% YoY NI but QoQ declines). Period-over-period trends reveal revenue growth in select names (Barfresh +33% YoY to $14.2M, BofA +7% YoY) offset by declines (Tradewinds -22% YoY, Edenor residential -1.6% YoY, M&T NII -2% QoQ), with margin pressures evident (Barfresh gross profit -15% YoY, M&T efficiency ratio 58.3% vs 55.1% QoQ). Capital allocation leans toward buybacks (M&T $1.25B repurchase) and equity raises (Tradewinds ~$1.17M), while forward-looking catalysts cluster in H2 2026 (Pasqal Nasdaq listing, Barfresh new facility operational). 13F-HR filings (17 instances) show institutional conviction in industrials-adjacent like AAR Corp, WW Grainger, FedEx via diversified portfolios. Sentiment skews neutral/mixed (28/50), with positive outliers in quantum/tech M&A and FDA designations signaling innovation alpha. Portfolio-level implication: Industrials poised for M&A-driven upside amid financing stability, but watch margin compression in ops-heavy firms.

18 high priority 32 medium 50 total filings
· daily

S&P 500 Energy Sector SEC Filings — April 15, 2026

Across 8 filings in the USA S&P 500 Energy intelligence stream, Hallador Energy Co (HNRG) dominates with bullish executive compensation enhancements, including CEO salary up 18.5% YoY to $800k and $68M 2026 Adj EBITDA target, alongside proxy filings for May 27 AGM highlighting 17.43% insider ownership. Other filings reveal mixed capital-raising activities, with Bioxytran narrowing net losses 10% YoY to $2.1M via G&A cuts (sales/marketing down 81% to $64.5k) but highly dilutive 20M+ share issuances at $0.025/share, and Zapata Quantum raising $3.75M in Series D toward $15M total. SPAC developments include Hall Chadwick's sponsor protections and AParadise's merger registration effective, targeting early May 2026 NYSE listing as $ENHA. No broad sector margin compression or revenue trends emerge due to non-operational focus, but period comparisons show cost discipline in Bioxytran and positive sentiment in raises/comp. Key implications: HNRG signals management conviction in coal/energy ops; dilution risks in microcaps; catalysts cluster in late May 2026. Portfolio theme: Selective bullishness in legacy energy (HNRG) amid SPAC/tech crossovers.

5 high priority 3 medium 8 total filings
· daily

US Material Events SEC 8-K Filings — April 15, 2026

Across 50 8-K filings dated around April 15, 2026, overarching themes include high executive churn (25+ appointments/resignations, neutral sentiment overall), strategic M&A/divestitures/JVs (12 deals totaling >$2B enterprise value), and financing renewals/extensions (12 credit agreements enhancing liquidity). Positive sentiment dominates (60% of filings), driven by comp packages signaling retention (e.g., Lionsgate CEO to 2031, Hallador +18.5% CEO salary), asset monetizations (Spire $650M sale), and investments (Graham $50M T. Rowe Price at $83.36/share). No explicit YoY/QoQ revenue declines noted, but proxy trends like salary hikes (+5-18.5%) and guidance affirmations (Spire FY26 EPS $5.25-$5.45) suggest management confidence; REIT concentration risks (Strawberry Fields 86.8% related-party rent) flag vulnerabilities. Portfolio-level: Energy/utilities show portfolio optimization (sales/JVs), biotech/pharma leadership builds for Phase 3 trials, implying H2 2026 catalysts. Market implications: Bullish deal-making environment supports alpha in transaction plays, but monitor leadership transitions for continuity risks.

50 high priority 50 total filings
· daily

Dow Jones 30 Stocks SEC Filings — April 15, 2026

Across 50 filings from the USA Dow Jones 30 intelligence stream (primarily blue-chip influenced but inclusive of sector peers), banking giants like Bank of America, PNC, and M&T demonstrate robust YoY growth with net income up 17%, 18%, and 14% respectively, driven by deposit/loan expansion (BAC +3% deposits, +9% loans; PNC +4% deposits, +7% loans) and NIM stability/expansion, signaling sector resilience amid acquisitions like PNC's FirstBank. Small-cap biotech/food/tech firms show mixed results: revenues volatile (Vivakor segments -84% to +87% YoY; Veea +57%), losses widening (CERO +140% net loss; Eightco massive $262M loss), offset by funding/dilution (Soluna SEPA $25M potential). M&A activity accelerates positively (Leidos JV $625M revenue contrib; Viant $40M TVision buy), while proxies flag routine governance (BRFH share increase, annual meetings June). 13F filings (20+) reveal institutional conviction in mega-caps/ETFs (MSFT/AAPL/NVDA ubiquitous; total AUM $10B+), but small caps face dilution/Nasdaq risks (Soluna delisting notice). Overarching: Banks outperform (avg +15% YoY NI), small caps underperform (avg revenue flat/declining, losses up), with catalysts in H2 M&A/earnings. Portfolio implication: Overweight banks, monitor small-cap turnarounds, hedge via 13F-tracked ETFs.

20 high priority 30 medium 50 total filings
· daily

US SEC Filings Daily Market Digest — April 15, 2026

Across 50 SEC filings for April 15, 2026, key themes include mixed financial results in 10-Ks with revenue declines in 6/12 reporting companies (avg -15% YoY, e.g., Eightco -16.76%, Tradewinds -22%) offset by growth in select areas like Chunghwa Telecom +2.7% YoY and Veea +57% YoY; aggressive capital allocation via repurchases (M&T $1.25B, News Corp $1B program) and offerings (TeraWulf $900M); biotech/pharma M&A momentum (Galera-Obsidian, Mission-Calavo); restructuring/layoffs (Snap 16% headcount cut for $500M savings); and delisting pressures on small caps (Soluna, Lunai reverse splits). Period-over-period trends show margin stability in banks (M&T NIM 3.71%) but efficiency ratio deterioration to 58.3%; institutional 13Fs reveal heavy ETF/tech concentration (e.g., Avondale iShares S&P 500 $37M). Critical developments like TeraWulf's upsized offering and Pasqal SPAC signal bullish crypto/quantum plays, while Sonim's zero revenue and Eightco's $262M loss flag distress; overall, opportunities in mergers outweigh risks in a quiet daily digest.

21 high priority 29 medium 50 total filings
· daily

S&P 500 Consumer Discretionary Sector SEC Filings — April 15, 2026

Across 50 filings primarily from financials, tech, SPACs, and REITs (despite Consumer Discretionary focus), Q1 2026 bank earnings show robust YoY growth (e.g., Bank of America NI +17%, revenue +7%; PNC NI +18% YoY) but mixed QoQ trends (First Horizon flat NI QoQ, PNC NII +6% QoQ offset by rising provisions). Debt issuances dominate for M&A, buybacks, and ops (TransDigm $1.5B for Stellant acq + $800M buybacks; Marvell $1B notes), signaling confidence in growth amid high leverage. SPAC/post-merger activity surges (Merlin S-1 for 66M+ shares, BOXABL S-4/A at $3.5B val, Pasqal H2 2026 Nasdaq via Bleichroeder), with positive funding/tech milestones. Capital allocation favors returns (OceanFirst $0.20 div, TransDigm buybacks) over cuts. 13F-HRs (20+ filings) reveal ETF-heavy portfolios (Vanguard S&P, tech giants) with no major shifts, indicating stability. REIT risks highlight concentration (Strawberry Fields 86.8% rent from 15 related leases). Forward catalysts cluster in Apr-May (debt closings, earnings), positioning tactical opportunities in financials/SPACs amid stable asset quality.

15 high priority 35 medium 50 total filings
· daily

S&P 500 Healthcare Sector SEC Filings — April 15, 2026

Across 50 filings in the S&P 500 Healthcare stream (though including cross-sector context via 13F holdings), dominant patterns emerge from 25+ 13F-HR disclosures showing institutional portfolios heavily weighted to mega-cap tech (AAPL, MSFT, NVDA averaging top 3 holdings at 10-25% allocation) and broad ETFs (e.g., SCHB, SPY), indicating conviction in resilient large-caps amid Q1 2026 positioning. Healthcare-specific highlights include Amgen's robust 10% YoY revenue/sales growth with 18 products at record sales and 14 exceeding $1B, Wave Life Sciences' redomiciliation to Delaware mid-2026 for cost savings, and Integra Lifesciences' $150M A/R facility extension to 2029 signaling liquidity strength. Period-over-period trends show mixed small-cap results (e.g., Citi Trends sales +8.9% YoY to profitability vs Tradewinds revenue -22% YoY, op ex +368%), while financials like PNC posted NII +6% QoQ/loans +7% but rising provisions/charge-offs. Capital allocation favors dividends (6 declarations/hikes, e.g., Costco +13% to $1.47/share), with limited buybacks beyond News Corp's $1B program. Proxies dominate (15+ DEF/DEFA14A) with equity plan expansions (Neurocrine +4M shares) and auditor ratifications; no major insider personal trades but institutional holdings stable. Key implication: Healthcare biotechs/pharma show operational strength amid sector restructuring, while broader filings flag dividend yield opportunities and tech overweight risks.

14 high priority 36 medium 50 total filings